Showing results (31-40 of 586) with videos related to
Sort By:
Pageof 59
Pharmacoepidemiology and Drug Safety|May 8, 2003
Improving communication of drug risks to prevent patient injury: proceedings of a workshopWilliam H Campbell, Robert M CaliffThe American Journal of Cardiology|February 24, 2007
Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular diseaseM Angelyn Bethel, Robert M CaliffLancet (London, England)|June 10, 2014
Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetesRury R Holman, Harald Sourij, Robert M CaliffClinical Trials (London, England)|March 4, 2015
Ethical and regulatory issues of pragmatic cluster randomized trials in contemporary health systemsMonique L Anderson, Robert M Califf, Jeremy Sugarman, et al.JAMA|October 15, 2024
FDA Perspective on the Regulation of Artificial Intelligence in Health Care and BiomedicineHaider J Warraich, Troy Tazbaz, Robert M CaliffCurrent Opinion in Oncology|May 1, 2002
Medical management of patients with brain tumorsPatrick Y Wen, Peter W MarksNeuro-Oncology|March 31, 2012
Treatment-related myelodysplasia in patients with primary brain tumorsJoachim M Baehring, Peter W MarksThe American Journal of Medicine|November 3, 2007
Clinical quality in non-ST-elevation acute coronary syndromesRobert M Califf, Rajendra H Mehta, Eric D PetersonNature Reviews. Drug Discovery|November 1, 2014
The Clinical Trials Transformation Initiative: innovation through collaborationPamela Tenaerts, Leanne Madre, Patrick Archdeacon, et al.NPJ Digital Medicine|April 10, 2025
Is regulatory science ready for artificial intelligence?Thomas Hartung, Maurice Whelan, Weida Tong, et al.Pageof 59